{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:19:46Z","timestamp":1791591586464,"version":"4.3.4"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00284-024-03994-1","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T18:08:37Z","timestamp":1733508517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Is Lactococcus lactis a Suitable Candidate for Use as a Vaccine Delivery System Against Helicobacter pylori?"],"prefix":"10.1007","volume":"82","author":[{"given":"Faria Hasanzadeh","family":"Haghighi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4738-0245","authenticated-orcid":false,"given":"Hadi","family":"Farsiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"issue":"2","key":"3994_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/oxfordjournals.epirev.a018040","volume":"22","author":"LM Brown","year":"2000","unstructured":"Brown LM (2000) Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22(2):283\u2013297","journal-title":"Epidemiol Rev"},{"issue":"2","key":"3994_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4110\/in.2015.15.2.51","volume":"15","author":"S Lee","year":"2015","unstructured":"Lee S, Nguyen MT (2015) Recent advances of vaccine adjuvants for infectious diseases. Immune Netw 15(2):51\u201357. https:\/\/doi.org\/10.4110\/in.2015.15.2.51","journal-title":"Immune Netw"},{"key":"3994_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apcsb.2015.03.001","volume":"99","author":"H Yang","year":"2015","unstructured":"Yang H, Kim DS (2015) Peptide immunotherapy in vaccine development: from epitope to adjuvant. Adv Protein Chem Struct Biol 99:1\u201314. https:\/\/doi.org\/10.1016\/bs.apcsb.2015.03.001","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"6","key":"3994_CR4","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/bs.apcsb.2015.03.001","volume":"29","author":"C-F Flach","year":"2011","unstructured":"Flach C-F, Svensson N, Blomquist M, Ekman A, Raghavan S, Holmgren J (2011) A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori. Vaccine 29(6):1235\u20131241. https:\/\/doi.org\/10.1016\/bs.apcsb.2015.03.001","journal-title":"Vaccine"},{"key":"3994_CR5","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2023.17","author":"R Mohammadzadeh","year":"2023","unstructured":"Mohammadzadeh R, Menbari S, Pishdadian A, Farsiani H (2023) Helicobacter pylori virulence factors: subversion of host immune system and development of various clinical outcomes. Expert Rev Mol Med. https:\/\/doi.org\/10.1017\/erm.2023.17","journal-title":"Expert Rev Mol Med"},{"key":"3994_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2944156","author":"H Yang","year":"2022","unstructured":"Yang H, Hu B (2022) Immunological perspective: Helicobacter pylori infection and gastritis. Mediat Inflamm. https:\/\/doi.org\/10.1155\/2022\/2944156","journal-title":"Mediat Inflamm"},{"key":"3994_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s40620-014-0039-2","volume":"27","author":"M Pakfetrat","year":"2014","unstructured":"Pakfetrat M, Basiri F, Malekmakan L, Roozbeh J (2014) Effects of turmeric on uremic pruritus in end stage renal disease patients: a double-blind randomized clinical trial. J Nephrol 27:203\u2013207","journal-title":"J Nephrol"},{"issue":"5","key":"3994_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1080\/00325481.2022.2063604","volume":"134","author":"H Yang","year":"2022","unstructured":"Yang H, Zhou X, Hu BJPM (2022) The \u2018reversibility\u2019of chronic atrophic gastritis after the eradication of Helicobacter pylori. Postgraduate Med 134(5):474\u20139. https:\/\/doi.org\/10.1080\/00325481.2022.2063604","journal-title":"Postgraduate Med"},{"issue":"11","key":"3994_CR9","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1038\/mt.2013.153","volume":"21","author":"M Ramachandran","year":"2013","unstructured":"Ramachandran M, Yu D, Wanders A, Essand M, Eriksson F (2013) An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors. Mol Ther 21(11):2008\u201318. https:\/\/doi.org\/10.1038\/mt.2013.153","journal-title":"Mol Ther"},{"issue":"12","key":"3994_CR10","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1056\/NEJMoa1708423","volume":"378","author":"IJ Choi","year":"2018","unstructured":"Choi IJ, Kook M-C, Kim Y-I, Cho S-J, Lee JY, Kim CG et al (2018) Helicobacter pylori therapy for the prevention of metachronous gastric cancer. New England J Med 378(12):1085\u201395. https:\/\/doi.org\/10.1056\/NEJMoa1708423","journal-title":"New England J Med"},{"key":"3994_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.127167","author":"A De Vries","year":"2007","unstructured":"De Vries A, Meijer G, Looman CW, Casparie M, Hansen B, van Grieken NC et al (2007) Epidemiological trends of pre-malignant gastric lesions; a long-term nationwide study in the Netherlands. Gut. https:\/\/doi.org\/10.1136\/gut.2007.127167","journal-title":"Gut"},{"issue":"10","key":"3994_CR12","doi-asserted-by":"publisher","first-page":"8928","DOI":"10.3390\/ijms24108928","volume":"24","author":"NAR Alias","year":"2023","unstructured":"Alias NAR, Hoo WPY, Siak PY, Othman SS, Mohammed Alitheen NB, In LLA, Abdul Rahim R, Song AAL (2023) Effect of secretion efficiency of mutant KRAS neoantigen by Lactococcus lactis on the immune response of a mucosal vaccine delivery vehicle targeting colorectal cancer. Int J Mol Sci 24(10):8928","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3994_CR13","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1089\/cmb.2019.0062","volume":"26","author":"VH Urrutia-Baca","year":"2019","unstructured":"Urrutia-Baca VH, Gomez-Flores R, De La Garza-Ramos MA, Tamez-Guerra P, Lucio-Sauceda DG, Rodr\u00edguez-Padilla MC (2019) Immunoinformatics approach to design a novel epitope-based oral vaccine against Helicobacter pylori. J Comput Biol 26(10):1177\u20131190. https:\/\/doi.org\/10.1089\/cmb.2019.0062","journal-title":"J Comput Biol"},{"key":"3994_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mib.2020.01.003","volume":"54","author":"X Zhang","year":"2020","unstructured":"Zhang X, Arnold IC, M\u00fcller A (2020) Mechanisms of persistence, innate immune activation and immunomodulation by the gastric pathogen Helicobacter pylori. Curr Opin Microbiol 54:1\u201310. https:\/\/doi.org\/10.1016\/j.mib.2020.01.003","journal-title":"Curr Opin Microbiol"},{"issue":"12","key":"3994_CR15","doi-asserted-by":"publisher","first-page":"7919","DOI":"10.1111\/jcmm.14682","volume":"23","author":"Y Sun","year":"2019","unstructured":"Sun Y, Zhang J (2019) Helicobacter pylori recrudescence and its influencing factors. J Cellular Mol Med 23(12):7919\u201325. https:\/\/doi.org\/10.1111\/jcmm.14682","journal-title":"J Cellular Mol Med"},{"key":"3994_CR16","doi-asserted-by":"publisher","unstructured":"Choudhury A, Ortiz P, Kearney CMJb. In vitro inhibition of H. pylori in a preferential manner using bioengineered L. lactis releasing guided antimicrobial peptides. 2021:2021.06. 11.448109. https:\/\/doi.org\/10.1101\/2021.06.11.448109","DOI":"10.1101\/2021.06.11.448109"},{"issue":"9","key":"3994_CR17","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1586\/erv.10.89","volume":"9","author":"MO Oyewumi","year":"2010","unstructured":"Oyewumi MO, Kumar A, Cui Z (2010) Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Rev Vaccines 9(9):1095\u20131107. https:\/\/doi.org\/10.1586\/erv.10.89","journal-title":"Expert Rev Vaccines"},{"issue":"37","key":"3994_CR18","doi-asserted-by":"publisher","first-page":"6224","DOI":"10.3748\/wjg.v27.i37.6224","volume":"27","author":"C Iino","year":"2021","unstructured":"Iino C, Shimoyama T (2021) Impact of Helicobacter pylori infection on gut microbiota. World J Gastroenterol 27(37):6224. https:\/\/doi.org\/10.3748\/wjg.v27.i37.6224","journal-title":"World J Gastroenterol"},{"issue":"8","key":"3994_CR19","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.vaccine.2003.09.002","volume":"22","author":"E-L Johansson","year":"2004","unstructured":"Johansson E-L, Bergquist C, Edebo A, Johansson C, Svennerholm A-M (2004) Comparison of different routes of vaccination for eliciting antibody responses in the human stomach. Vaccine 22(8):984\u2013990. https:\/\/doi.org\/10.1016\/j.vaccine.2003.09.002","journal-title":"Vaccine"},{"key":"3994_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.25.542131","author":"JA Bugaytsova","year":"2023","unstructured":"Bugaytsova JA, Piddubnyi A, Tkachenko I, Rakhimova L, Edlund JO, Thorell K et al (2023) Vaccination with Helicobacter pylori attachment proteins protects against gastric cancer. Biorxiv. https:\/\/doi.org\/10.1101\/2023.05.25.542131","journal-title":"Biorxiv"},{"issue":"3","key":"3994_CR21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.mib.2013.06.002","volume":"16","author":"LG Berm\u00fadez-Humar\u00e1n","year":"2013","unstructured":"Berm\u00fadez-Humar\u00e1n LG, Aubry C, Motta J-P, Deraison C, Steidler L, Vergnolle N et al (2013) Engineering lactococci and lactobacilli for human health. Curr Opin Microbiol 16(3):278\u2013283. https:\/\/doi.org\/10.1016\/j.mib.2013.06.002","journal-title":"Curr Opin Microbiol"},{"issue":"31","key":"3994_CR22","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1016\/j.vaccine.2014.05.054","volume":"32","author":"B Ahmed","year":"2014","unstructured":"Ahmed B, Loos M, Vanrompay D, Cox E (2014) Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157: H7 in a murine model of colonization. Vaccine 32(31):3909\u20133916. https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.054","journal-title":"Vaccine"},{"issue":"8","key":"3994_CR23","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3390\/molecules22081255","volume":"22","author":"MP Mokoena","year":"2017","unstructured":"Mokoena MP (2017) Lactic acid bacteria and their bacteriocins: classification, biosynthesis and applications against uropathogens: a mini-review. Molecules 22(8):1255. https:\/\/doi.org\/10.3390\/molecules22081255","journal-title":"Molecules"},{"issue":"3","key":"3994_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3920\/BM2013.0057","volume":"5","author":"R Mart\u00edn","year":"2014","unstructured":"Mart\u00edn R, Miquel S, Ulmer J, Langella P, Bermudez-Humaran L (2014) Gut ecosystem: how microbes help us. Beneficial Microbes 5(3):219\u2013233. https:\/\/doi.org\/10.3920\/BM2013.0057","journal-title":"Beneficial Microbes"},{"issue":"1","key":"3994_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-1605(96)01233-0","volume":"36","author":"ME Stiles","year":"1997","unstructured":"Stiles ME, Holzapfel WH (1997) Lactic acid bacteria of foods and their current taxonomy. Int J Food Microbiol 36(1):1\u201329. https:\/\/doi.org\/10.1016\/S0168-1605(96)01233-0","journal-title":"Int J Food Microbiol"},{"key":"3994_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.517166","volume":"8","author":"LM Tavares","year":"2020","unstructured":"Tavares LM, De Jesus LC, Da Silva TF, Barroso FA, Batista VL, Coelho-Rocha ND et al (2020) Novel strategies for efficient production and delivery of live biotherapeutics and biotechnological uses of Lactococcus lactis: the lactic acid bacterium model. Front Bioeng Biotechnol 8:517166. https:\/\/doi.org\/10.3389\/fbioe.2020.517166","journal-title":"Front Bioeng Biotechnol"},{"key":"3994_CR27","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00253-012-4407-3","volume":"96","author":"Y-T Tsai","year":"2012","unstructured":"Tsai Y-T, Cheng P-C, Pan T-M (2012) The immunomodulatory effects of lactic acid bacteria for improving immune functions and benefits. Appl Microbiol Biotechnol 96:853\u2013862. https:\/\/doi.org\/10.1007\/s00253-012-4407-3","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"3994_CR28","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3892\/ol.2013.1743","volume":"7","author":"Y Li","year":"2014","unstructured":"Li Y, Li X, Liu H, Zhuang S, Yang J, Zhang F (2014) Intranasal immunization with recombinant Lactococci carrying human papillomavirus E7 protein and mouse interleukin-12 DNA induces E7-specific antitumor effects in C57BL\/6 mice. Oncol Lett 7(2):576\u2013582. https:\/\/doi.org\/10.3892\/ol.2013.1743","journal-title":"Oncol Lett"},{"issue":"23\u201324","key":"3994_CR29","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3892\/ol.2013.1743","volume":"16","author":"NR Hegde","year":"2011","unstructured":"Hegde NR, Kaveri SV, Bayry J (2011) Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination. Drug Discovery Today 16(23\u201324):1061\u20131068. https:\/\/doi.org\/10.3892\/ol.2013.1743","journal-title":"Drug Discovery Today"},{"key":"3994_CR30","doi-asserted-by":"publisher","first-page":"918160","DOI":"10.3389\/fimmu.2022.918160","volume":"13","author":"L Guo","year":"2022","unstructured":"Guo L, Zhang F, Wang S, Li R, Zhang L, Zhang Z et al (2022) Oral immunization with a M cell-targeting recombinant L. lactis vaccine LL-plSAM-FVpE stimulate protective immunity against H. pylori in mice. Front Immunol 13:918160. https:\/\/doi.org\/10.3389\/fimmu.2022.918160","journal-title":"Front Immunol"},{"key":"3994_CR31","doi-asserted-by":"publisher","first-page":"103926","DOI":"10.1016\/j.micpath.2019.103926","volume":"142","author":"MR Aliramaei","year":"2020","unstructured":"Aliramaei MR, Khorasgani MR, Rahmani MR, Esfahani SHZ (2020) Emamzadeh RJMp. Expression of Helicobacter pylori CagL gene in Lactococcus lactis MG1363 and evaluation of its immunogenicity as an oral vaccine in mice. Microbial Pathogenesis 142:103926. https:\/\/doi.org\/10.1016\/j.micpath.2019.103926","journal-title":"Microbial Pathogenesis"},{"key":"3994_CR32","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.2147\/IJN.S72318","volume":"9","author":"L Pan","year":"2014","unstructured":"Pan L, Zhang Z, Lv J, Zhou P, Hu W, Fang Y et al (2014) Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles. Int J Nanomed 9:5603\u201318","journal-title":"Int J Nanomed"},{"issue":"11","key":"3994_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027605","volume":"6","author":"G Wang","year":"2011","unstructured":"Wang G, Pan L, Zhang Y, Wang Y, Zhang Z, L\u00fc J et al (2011) Intranasal delivery of cationic PLGA nano\/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge. PLoS ONE 6(11):e27605. https:\/\/doi.org\/10.1371\/journal.pone.0027605","journal-title":"PLoS ONE"},{"key":"3994_CR34","doi-asserted-by":"publisher","unstructured":"des Rieux A, Fievez V, Garinot M, Schneider Y-J, Pr\u00e9at VJJocr. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. 2006;116(1):1\u201327. https:\/\/doi.org\/10.1016\/j.jconrel.2006.08.013","DOI":"10.1016\/j.jconrel.2006.08.013"},{"issue":"3","key":"3994_CR35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0161-5890(91)90076-V","volume":"28","author":"JH Eldridge","year":"1991","unstructured":"Eldridge JH, Staas JK, Meulbroek JA, McGhee JR, Tice TR, Gilley RM (1991) Biodegradable microspheres as a vaccine delivery system. Mol Immunol 28(3):287\u201394. https:\/\/doi.org\/10.1016\/0161-5890(91)90076-V","journal-title":"Mol Immunol"},{"issue":"11","key":"3994_CR36","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3390\/pharmaceutics13111892","volume":"13","author":"H Chen","year":"2021","unstructured":"Chen H, Ji H, Kong X, Lei P, Yang Q, Wu W et al (2021) Bacterial ghosts-based vaccine and drug delivery systems. Pharmaceutics 13(11):1892. https:\/\/doi.org\/10.3390\/pharmaceutics13111892","journal-title":"Pharmaceutics"},{"issue":"2\u20133","key":"3994_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0928-8244(03)00068-3","volume":"37","author":"A Stevenson","year":"2003","unstructured":"Stevenson A, Roberts MJFI, Microbiology M (2003) Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens. FEMS Immunol Med Microbiol 37(2\u20133):121\u20138. https:\/\/doi.org\/10.1016\/S0928-8244(03)00068-3","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"13\u201314","key":"3994_CR38","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/S0264-410X(00)00354-6","volume":"19","author":"E Medina","year":"2001","unstructured":"Medina E, Guzm\u00e1n CA (2001) Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. Vaccine 19(13\u201314):1573\u20131580","journal-title":"Vaccine"},{"issue":"2","key":"3994_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.pep.2011.06.005","volume":"79","author":"DS Pontes","year":"2011","unstructured":"Pontes DS, De Azevedo MSP, Chatel JM, Langella P, Azevedo V, Miyoshi A et al (2011) Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems. Protein Expr Purif 79(2):165\u2013175","journal-title":"Protein Expr Purif"},{"issue":"3","key":"3994_CR40","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00001432-200306000-00008","volume":"16","author":"SF Lee","year":"2003","unstructured":"Lee SF (2003) Oral colonization and immune responses to Streptococcus gordonii: potential use as a vector to induce antibodies against respiratory pathogens. Curr Opin Infectious Dis 16(3):231\u20135","journal-title":"Curr Opin Infectious Dis"},{"issue":"11","key":"3994_CR41","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.2174\/1389201024666221220113517","volume":"24","author":"PL Patil","year":"2023","unstructured":"Patil PL, Gharat SK, Jadhav KR, Kadam VJ (2023) Engineered bacteria: general overview as therapeutic agent and a novel drug delivery system. Curr Pharm Biotechnol 24(11):1351\u20131364. https:\/\/doi.org\/10.2174\/1389201024666221220113517","journal-title":"Curr Pharm Biotechnol"},{"key":"3994_CR42","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S412361","author":"S Li","year":"2023","unstructured":"Li S, Zhao W, Xia L, Kong L, Yang L (2023) How long will it take to launch an effective helicobacter pylori vaccine for humans? Infect Drug Resistance. https:\/\/doi.org\/10.2147\/IDR.S412361","journal-title":"Infect Drug Resistance"},{"key":"3994_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00244","author":"AD Walsham","year":"2016","unstructured":"Walsham AD, MacKenzie DA, Cook V, Wemyss-Holden S, Hews CL, Juge N et al (2016) Lactobacillus reuteri inhibition of enteropathogenic Escherichia coli adherence to human intestinal epithelium. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2016.00244","journal-title":"Front Microbiol"},{"issue":"3","key":"3994_CR44","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1111\/jcmm.13496","volume":"22","author":"R Wasfi","year":"2018","unstructured":"Wasfi R, Abd El-Rahman OA, Zafer MM, Ashour HM (2018) Probiotic Lactobacillus sp. inhibit growth, biofilm formation and gene expression of caries-inducing Streptococcus mutans. J Cellular Mol Med 22(3):1972\u201383. https:\/\/doi.org\/10.1111\/jcmm.13496","journal-title":"J Cellular Mol Med"},{"key":"3994_CR45","doi-asserted-by":"publisher","first-page":"1000517","DOI":"10.3389\/fnut.2022.1000517","volume":"9","author":"S You","year":"2022","unstructured":"You S, Ma Y, Yan B, Pei W, Wu Q, Ding C et al (2022) The promotion mechanism of prebiotics for probiotics: a review. Front Nutr 9:1000517. https:\/\/doi.org\/10.3389\/fnut.2022.1000517","journal-title":"Front Nutr"},{"issue":"12","key":"3994_CR46","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S0167-7799(02)02075-9","volume":"20","author":"JF Seegers","year":"2002","unstructured":"Seegers JF (2002) Lactobacilli as live vaccine delivery vectors: progress and prospects. Trends Biotechnol 20(12):508\u201315. https:\/\/doi.org\/10.1016\/S0167-7799(02)02075-9","journal-title":"Trends Biotechnol"},{"issue":"6","key":"3994_CR47","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1128\/AEM.68.6.3166-3168.2002","volume":"68","author":"S Drouault","year":"2002","unstructured":"Drouault S, Juste C, Marteau P, Renault P, Corthier GJA, Microbiology E (2002) Oral treatment with Lactococcus lactis expressing Staphylococcus hyicus lipase enhances lipid digestion in pigs with induced pancreatic insufficiency. Appl Environ Microbiol 68(6):3166\u20138. https:\/\/doi.org\/10.1128\/AEM.68.6.3166-3168.2002","journal-title":"Appl Environ Microbiol"},{"key":"3994_CR48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF02814197","volume":"40","author":"P Norton","year":"1995","unstructured":"Norton P, Le Page R, Wells JW (1995) Progress in the development of Lactococcus lactis as a recombinant mucosal vaccine delivery system. Folia Microbiologica 40:225\u201330. https:\/\/doi.org\/10.1007\/BF02814197","journal-title":"Folia Microbiologica"},{"issue":"1","key":"3994_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1586\/14760584.6.1.97","volume":"6","author":"D Daudel","year":"2007","unstructured":"Daudel D, Weidinger G, Spreng S (2007) Use of attenuated bacteria as delivery vectors for DNA vaccines. Expert Rev Vaccines 6(1):97\u2013110. https:\/\/doi.org\/10.1586\/14760584.6.1.97","journal-title":"Expert Rev Vaccines"},{"issue":"1\u20132","key":"3994_CR50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0168-1605(98)00128-7","volume":"44","author":"S Salminen","year":"1998","unstructured":"Salminen S, von Wright A, Morelli L, Marteau P, Brassart D, de Vos WM et al (1998) Demonstration of safety of probiotics\u2014a review. Int J Food Microbiol 44(1\u20132):93\u2013106. https:\/\/doi.org\/10.1016\/S0168-1605(98)00128-7","journal-title":"Int J Food Microbiol"},{"issue":"6","key":"3994_CR51","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/jb\/mvh181","volume":"136","author":"A Wada","year":"2004","unstructured":"Wada A, Yamasaki E, Hirayama T (2004) Helicobacter pylori vacuolating cytotoxin, VacA, is responsible for gastric ulceration. J Biochem 136(6):741\u2013746","journal-title":"J Biochem"},{"issue":"5","key":"3994_CR52","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrmicro1840","volume":"6","author":"JM Wells","year":"2008","unstructured":"Wells JM, Mercenier A (2008) Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 6(5):349\u2013362","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"3994_CR53","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1139\/W08-052","volume":"54","author":"J Villena","year":"2008","unstructured":"Villena J, Medina M, Vintini E, Alvarez S (2008) Stimulation of respiratory immunity by oral administration of Lactococcus lactis. Canadian J Microbiol 54(8):630\u2013638","journal-title":"Canadian J Microbiol"},{"issue":"7","key":"3994_CR54","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nbt0797-653","volume":"15","author":"K Robinson","year":"1997","unstructured":"Robinson K, Chamberlain LM, Schofield KM, Wells JM, Le Page RW (1997) Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat Biotechnol 15(7):653\u2013657","journal-title":"Nat Biotechnol"},{"key":"3994_CR55","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.micinf.2007.07.010","volume":"9","author":"VES Dom\u00e8nech","year":"2007","unstructured":"Dom\u00e8nech VES, Panthel K, Meinel KM, Winter SE, R\u00fcssmann HJM (2007) Infection. Pre-existing anti-Salmonella vector immunity prevents the development of protective antigen-specific CD8 T-cell frequencies against murine listeriosis. Microbes Infection 9:1447\u201353. https:\/\/doi.org\/10.1016\/j.micinf.2007.07.010","journal-title":"Microbes Infection"},{"key":"3994_CR56","doi-asserted-by":"publisher","unstructured":"Jana S, Deb JJAm, biotechnology. Retracted article: Strategies for efficient production of heterologous proteins in Escherichia coli. 2005;67:289-98. https:\/\/doi.org\/10.1007\/s00253-014-5822-4","DOI":"10.1007\/s00253-014-5822-4"},{"issue":"1\u20133","key":"3994_CR57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000106082","volume":"14","author":"E Morello","year":"2007","unstructured":"Morello E, Bermudez-Humaran L, Llull D, Sole V, Miraglio N, Langella P et al (2007) Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion. Microb Physiol 14(1\u20133):48\u201358. https:\/\/doi.org\/10.1159\/000106082","journal-title":"Microb Physiol"},{"issue":"1","key":"3994_CR58","first-page":"102","volume":"2","author":"S Nouaille","year":"2003","unstructured":"Nouaille S, Ribeiro LA, Miyoshi A, Pontes D, Le Loir Y, Oliveira SC et al (2003) Heterologous protein production and delivery systems for Lactococcus lactis. Genet Mol Res 2(1):102\u201311","journal-title":"Genet Mol Res"},{"issue":"5","key":"3994_CR59","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1101\/gr.169701","volume":"11","author":"A Bolotin","year":"2001","unstructured":"Bolotin A, Wincker P, Mauger S, Jaillon O, Malarme K, Weissenbach J et al (2001) The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res 11(5):731\u201353. https:\/\/doi.org\/10.1101\/gr.169701","journal-title":"Genome Res"},{"issue":"1","key":"3994_CR60","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0378-1119(90)90428-T","volume":"95","author":"M van Asseldonk","year":"1990","unstructured":"van Asseldonk M, Rutten G, Oteman M, Siezen RJ, de Vos WM, Simons GJG (1990) Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363. Gene 95(1):155\u201360. https:\/\/doi.org\/10.1016\/0378-1119(90)90428-T","journal-title":"Gene"},{"issue":"2","key":"3994_CR61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.pep.2011.06.005","volume":"79","author":"DS Pontes","year":"2011","unstructured":"Pontes DS, De Azevedo MSP, Chatel J-M, Langella P, Azevedo V, Miyoshi A (2011) Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems. Protein Expr Purif 79(2):165\u2013175. https:\/\/doi.org\/10.1016\/j.pep.2011.06.005","journal-title":"Protein Expr Purif"},{"key":"3994_CR62","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00253-019-09628-y","volume":"103","author":"TV Plavec","year":"2019","unstructured":"Plavec TV, Berlec A (2019) Engineering of lactic acid bacteria for delivery of therapeutic proteins and peptides. Appl Microbiol Biotechnol 103:2053\u20132066. https:\/\/doi.org\/10.1007\/s00253-019-09628-y","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"3994_CR63","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/156652310790945557","volume":"10","author":"M Bahey-El-Din","year":"2010","unstructured":"Bahey-El-Din M, Gahan CG, Griffin BT (2010) Lactococcus lactis as a cell factory for delivery of therapeutic proteins. Curr Gene Ther 10(1):34\u201345. https:\/\/doi.org\/10.2174\/156652310790945557","journal-title":"Curr Gene Ther"},{"issue":"6\u20137","key":"3994_CR64","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/S0264-410X(96)00241-1","volume":"15","author":"PM Norton","year":"1997","unstructured":"Norton PM, Wells JM, Brown HWG, Macpherson AM, Le Page RWF (1997) Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C. Vaccine 15(6\u20137):616\u2013619","journal-title":"Vaccine"},{"key":"3994_CR65","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/750932","author":"X-J Zhang","year":"2015","unstructured":"Zhang X-J, Feng S-Y, Li Z-T, Feng Y-M (2015) Practice. Expression of Helicobacter pylori hspA gene in Lactococcus lactis NICE system and experimental study on its immunoreactivity. Gastroenterol Res Practice. https:\/\/doi.org\/10.1155\/2015\/750932","journal-title":"Gastroenterol Res Practice"},{"issue":"5","key":"3994_CR66","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1128\/iai.72.5.2753-2761.2004","volume":"72","author":"K Robinson","year":"2004","unstructured":"Robinson K, Chamberlain L, Lopez M, Rush C, Marcotte H, Le Page R et al (2004) Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. Infect Immun 72(5):2753\u201361. https:\/\/doi.org\/10.1128\/iai.72.5.2753-2761.2004","journal-title":"Infect Immun"},{"issue":"7","key":"3994_CR67","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1128\/iai.66.7.3183-3189.1998","volume":"66","author":"L Steidler","year":"1998","unstructured":"Steidler L, Robinson K, Chamberlain L, Schofield KM, Remaut E, Le Page RW et al (1998) Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect Immun 66(7):3183\u20139. https:\/\/doi.org\/10.1128\/iai.66.7.3183-3189.1998","journal-title":"Infect Immun"},{"key":"3994_CR68","doi-asserted-by":"publisher","first-page":"517166","DOI":"10.3389\/fbioe.2020.517166","volume":"8","author":"LM Tavares","year":"2020","unstructured":"Tavares LM, De Jesus LC, Da Silva TF, Barroso FA, Batista VL, Coelho-Rocha ND et al (2020) Novel strategies for efficient production and delivery of live biotherapeutics and biotechnological uses of Lactococcus lactis: the lactic acid bacterium model. Front Bioeng Biotechnol 8:517166. https:\/\/doi.org\/10.3389\/fbioe.2020.517166","journal-title":"Front Bioeng Biotechnol"},{"issue":"7","key":"3994_CR69","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1128\/JB.180.7.1904-1912.1998","volume":"180","author":"I Poquet","year":"1998","unstructured":"Poquet I, Ehrlich SD, Gruss A (1998) An export-specific reporter designed for gram-positive bacteria: application to Lactococcus lactis. J Bacteriol 180(7):1904\u20131912","journal-title":"J Bacteriol"},{"issue":"1\u20133","key":"3994_CR70","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0168-1605(00)00179-3","volume":"55","author":"P Duwat","year":"2000","unstructured":"Duwat P, Cesselin B, Sourice S, Gruss A (2000) Lactococcus lactis, a bacterial model for stress responses and survival. Int J Food Microbiol 55(1\u20133):83\u20136. https:\/\/doi.org\/10.1016\/S0168-1605(00)00179-3","journal-title":"Int J Food Microbiol"},{"issue":"2","key":"3994_CR71","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/biom12020180","volume":"12","author":"A Frelet-Barrand","year":"2022","unstructured":"Frelet-Barrand A (2022) Lactococcus lactis, an attractive cell factory for the expression of functional membrane proteins. Biomolecules 12(2):180. https:\/\/doi.org\/10.3390\/biom12020180","journal-title":"Biomolecules"},{"key":"3994_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-5-39","volume":"5","author":"AP Oliveira","year":"2005","unstructured":"Oliveira AP, Nielsen J, F\u00f6rster J (2005) Modeling Lactococcus lactis using a genome-scale flux model. BMC Microbiol 5:1\u201315. https:\/\/doi.org\/10.1186\/1471-2180-5-39","journal-title":"BMC Microbiol"},{"issue":"5","key":"3994_CR73","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1128\/aem.33.5.1233-1236.1977","volume":"33","author":"L Ingram","year":"1977","unstructured":"Ingram L (1977) Changes in lipid composition of Escherichia coli resulting from growth with organic solvents and with food additives. Appl Environ Microbiol 33(5):1233\u20131236. https:\/\/doi.org\/10.1128\/aem.33.5.1233-1236.1977","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"3994_CR74","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/biom12020180","volume":"12","author":"A Frelet-Barrand","year":"2022","unstructured":"Frelet-Barrand A (2022) Lactococcus lactis, an attractive cell factory for the expression of functional membrane proteins. Biomolecules 12(2):180. https:\/\/doi.org\/10.3390\/biom12020180","journal-title":"Biomolecules"},{"issue":"4","key":"3994_CR75","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.vaccine.2011.11.098","volume":"30","author":"MJV Bahey-El-Din","year":"2012","unstructured":"Bahey-El-Din MJV (2012) Lactococcus lactis-based vaccines from laboratory bench to human use: an overview. Vaccine 30(4):685\u201390. https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.098","journal-title":"Vaccine"},{"issue":"5","key":"3994_CR76","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.fm.2005.06.003","volume":"23","author":"D-W Jeong","year":"2006","unstructured":"Jeong D-W, Lee J-H, Kim KH, Lee HJ (2006) A food-grade expression\/secretion vector for Lactococcus lactis that uses an \u03b1-galactosidase gene as a selection marker. Food Microbiol 23(5):468\u201375. https:\/\/doi.org\/10.1016\/j.fm.2005.06.003","journal-title":"Food Microbiol"},{"issue":"3","key":"3994_CR77","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1139\/cjm-2015-0596","volume":"62","author":"W Lu","year":"2016","unstructured":"Lu W, Wang T, Wang Y, Xin M, Kong J (2016) A food-grade fimbrial adhesin FaeG expression system in Lactococcus lactis and Lactobacillus casei. Can J Microbiol 62(3):241\u2013248. https:\/\/doi.org\/10.1139\/cjm-2015-0596","journal-title":"Can J Microbiol"},{"issue":"2","key":"3994_CR78","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1574-6976.2005.00011","volume":"30","author":"S Mills","year":"2006","unstructured":"Mills S, McAuliffe OE, Coffey A, Fitzgerald GF, Ross RP (2006) Plasmids of lactococci\u2013genetic accessories or genetic necessities? FEMS Microbiol Rev 30(2):243\u201373. https:\/\/doi.org\/10.1111\/j.1574-6976.2005.00011","journal-title":"FEMS Microbiol Rev"},{"key":"3994_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12934-016-0468-9","volume":"15","author":"C Michon","year":"2016","unstructured":"Michon C, Langella P, Eijsink V, Mathiesen G, Chatel J-M (2016) Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications. Microbial Cell Factories 15:1\u201316. https:\/\/doi.org\/10.1186\/s12934-016-0468-9","journal-title":"Microbial Cell Factories"},{"key":"3994_CR80","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1186\/s12934-016-0468-9","volume":"65","author":"J-L Gaillard","year":"1991","unstructured":"Gaillard J-L, Berche P, Frehel C, Gouln E, Cossart P (1991) Entry of L. monocytogenes into cells is mediated by internalin, a repeat protein reminiscent of surface antigens from gram-positive cocci. Cell 65:1127\u201341. https:\/\/doi.org\/10.1186\/s12934-016-0468-9","journal-title":"Cell"},{"key":"3994_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-0556-7-4","volume":"7","author":"V Guimar\u00e3es","year":"2009","unstructured":"Guimar\u00e3es V, Innocentin S, Chatel J-M, Lef\u00e8vre F, Langella P, Azevedo V et al (2009) A new plasmid vector for DNA delivery using lactococci. Genetic Vaccin Ther 7:1\u20137. https:\/\/doi.org\/10.1186\/1479-0556-7-4","journal-title":"Genetic Vaccin Ther"},{"issue":"14","key":"3994_CR82","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.1128\/AEM.00825-09","volume":"75","author":"S Innocentin","year":"2009","unstructured":"Innocentin S, Guimaraes V, Miyoshi A, Azevedo V, Langella P, Chatel J-M et al (2009) Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells. Appl Environ Microbiol 75(14):4870\u20134878. https:\/\/doi.org\/10.1128\/AEM.00825-09","journal-title":"Appl Environ Microbiol"},{"issue":"5","key":"3994_CR83","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3920\/BM2018.0157","volume":"10","author":"J Liu","year":"2019","unstructured":"Liu J, Yang G, Gao X, Zhang Z, Liu Y, Liu Q et al (2019) Recombinant invasive Lactobacillus plantarum expressing fibronectin binding protein A induce specific humoral immune response by stimulating differentiation of dendritic cells. Beneficial Microbes 10(5):589\u2013604. https:\/\/doi.org\/10.3920\/BM2018.0157","journal-title":"Beneficial Microbes"},{"issue":"04","key":"3994_CR84","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1160\/TH06-11-0640","volume":"97","author":"R Heying","year":"2007","unstructured":"Heying R, van de Gevel J, Que Y-A, Moreillon P, Beekhuizen H (2007) Fibronectin-binding proteins and clumping factor A in Staphylococcus aureus experimental endocarditis: FnBPA is sufficient to activate human endothelial cells. Thromb Haemost 97(04):617\u2013626. https:\/\/doi.org\/10.1160\/TH06-11-0640","journal-title":"Thromb Haemost"},{"issue":"6","key":"3994_CR85","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00253-005-0107-6","volume":"68","author":"I Mierau","year":"2005","unstructured":"Mierau I, Kleerebezem M (2005) 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Biotechnol 68(6):705\u2013717. https:\/\/doi.org\/10.1007\/s00253-005-0107-6","journal-title":"Appl Microbiol Biotechnol"},{"key":"3994_CR86","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00253-004-1555-0","volume":"65","author":"A Simoes-Barbosa","year":"2004","unstructured":"Simoes-Barbosa A, Abreu H, Silva Neto A, Gruss A, Langella P (2004) A food-grade delivery system for Lactococcus lactis and evaluation of inducible gene expression. Appl Microbiol Biotechnol 65:61\u201367. https:\/\/doi.org\/10.1007\/s00253-004-1555-0","journal-title":"Appl Microbiol Biotechnol"},{"issue":"11","key":"3994_CR87","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1691\/ph.2012.1705","volume":"67","author":"A Berlec","year":"2012","unstructured":"Berlec A, Ravnikar M, \u0160trukelj B (2012) Lactic acid bacteria as oral delivery systems for biomolecules. Die Pharmazie-An Int J Pharm Sci 67(11):891\u2013898. https:\/\/doi.org\/10.1691\/ph.2012.1705","journal-title":"Die Pharmazie-An Int J Pharm Sci"},{"issue":"5","key":"3994_CR88","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/j.1574-6976.2011.00323","volume":"36","author":"CE Price","year":"2012","unstructured":"Price CE, Zeyniyev A, Kuipers OP, Kok J (2012) From meadows to milk to mucosa\u2013adaptation of Streptococcus and Lactococcus species to their nutritional environments. FEMS Microbiol Rev 36(5):949\u2013971. https:\/\/doi.org\/10.1111\/j.1574-6976.2011.00323","journal-title":"FEMS Microbiol Rev"},{"key":"3994_CR89","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.actbio.2018.08.033","volume":"80","author":"J Lee","year":"2018","unstructured":"Lee J, Kumar SA, Jhan YY, Bishop CJ (2018) Engineering DNA vaccines against infectious diseases. Acta Biomater 80:31\u201347. https:\/\/doi.org\/10.1016\/j.actbio.2018.08.033","journal-title":"Acta Biomater"},{"key":"3994_CR90","doi-asserted-by":"publisher","first-page":"79","DOI":"10.21775\/cimb.022.079","volume":"22","author":"AI Myhr","year":"2017","unstructured":"Myhr AI (2017) DNA vaccines: regulatory considerations and safety aspects. Curr Issues Mol Biol 22:79\u201388. https:\/\/doi.org\/10.21775\/cimb.022.079","journal-title":"Curr Issues Mol Biol"},{"issue":"2","key":"3994_CR91","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/cei.13352","volume":"198","author":"R New","year":"2019","unstructured":"New R (2019) Formulation technologies for oral vaccines. Clin Exp Immunol 198(2):153\u2013169. https:\/\/doi.org\/10.1111\/cei.13352","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"3994_CR92","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/polym10090948","volume":"10","author":"SH Kang","year":"2018","unstructured":"Kang SH, Hong SJ, Lee Y-K, Cho S (2018) Oral vaccine delivery for intestinal immunity\u2014biological basis, barriers, delivery system, and m cell targeting. Polymers 10(9):948. https:\/\/doi.org\/10.3390\/polym10090948","journal-title":"Polymers"},{"issue":"3","key":"3994_CR93","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrmicro2297","volume":"8","author":"S Lebeer","year":"2010","unstructured":"Lebeer S, Vanderleyden J, De Keersmaecker SC (2010) Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 8(3):171\u2013184. https:\/\/doi.org\/10.1038\/nrmicro2297","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"3994_CR94","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1128\/cmr.14.2.430-445.2001","volume":"14","author":"PL Ogra","year":"2001","unstructured":"Ogra PL, Faden H, Welliver RC (2001) Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 14(2):430\u2013445. https:\/\/doi.org\/10.1128\/cmr.14.2.430-445.2001","journal-title":"Clin Microbiol Rev"},{"issue":"14","key":"3994_CR95","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1016\/j.vaccine.2006.12.026","volume":"25","author":"J Nystr\u00f6m","year":"2007","unstructured":"Nystr\u00f6m J, Svennerholm A-MJV (2007) Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses. Vaccine 25(14):2591\u20138. https:\/\/doi.org\/10.1016\/j.vaccine.2006.12.026","journal-title":"Vaccine"},{"issue":"1","key":"3994_CR96","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1046\/j.1440-1711.2000.00881.x","volume":"78","author":"P Sutton","year":"2000","unstructured":"Sutton P, Wilson J, Kosaka T, Wolowczuk I, Lee A (2000) Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies. Immunol Cell Biol 78(1):28\u201330","journal-title":"Immunol Cell Biol"},{"issue":"6","key":"3994_CR97","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/S0016-5085(97)70004-0","volume":"113","author":"M Mohammadi","year":"1997","unstructured":"Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn SJJG (1997) Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 113(6):1848\u201357. https:\/\/doi.org\/10.1016\/S0016-5085(97)70004-0","journal-title":"Gastroenterology"},{"issue":"7","key":"3994_CR98","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1053\/j.gastro.2009.02.077","volume":"136","author":"D Velin","year":"2009","unstructured":"Velin D, Favre L, Bernasconi E, Bachmann D, Pythoud C, Saiji E et al (2009) Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology 136(7):2237\u201346.e1. https:\/\/doi.org\/10.1053\/j.gastro.2009.02.077","journal-title":"Gastroenterology"},{"key":"3994_CR99","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s10529-016-2209-x","volume":"38","author":"R Zhang","year":"2016","unstructured":"Zhang R, Peng X, Duan G, Shi Q, Chen S, Wang C et al (2016) An engineered Lactococcus lactis strain exerts significant immune responses through efficient expression and delivery of Helicobacter pylori Lpp20 antigen. Biotechnol Lett 38:2169\u201375. https:\/\/doi.org\/10.1007\/s10529-016-2209-x","journal-title":"Biotechnol Lett"},{"issue":"3","key":"3994_CR100","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1574-695X.2009.00566.x","volume":"56","author":"Q Gu","year":"2009","unstructured":"Gu Q, Song D, Zhu M (2009) Oral vaccination of mice against Helicobacter pylori with recombinant Lactococcus lactis expressing urease subunit B. FEMS Immunol Med Microbiol 56(3):197\u2013203","journal-title":"FEMS Immunol Med Microbiol"},{"key":"3994_CR101","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1016\/S0264-410X(01)00119-0","volume":"19","author":"MH Lee","year":"2001","unstructured":"Lee MH, Roussel Y, Wilks M, Tabaqchali SJV (2001) Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice. Vaccine 19:3927\u201335. https:\/\/doi.org\/10.1016\/S0264-410X(01)00119-0","journal-title":"Vaccine"},{"issue":"2","key":"3994_CR102","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jaci.2016.06.018","volume":"139","author":"K Stein","year":"2017","unstructured":"Stein K, Brand S, Jenckel A, Sigmund A, Chen ZJ, Kirschning CJ et al (2017) Endosomal recognition of Lactococcus lactis G121 and its RNA by dendritic cells is key to its allergy-protective effects. J Allergy Clin Immunol 139(2):667\u201378.e5. https:\/\/doi.org\/10.1016\/j.jaci.2016.06.018","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"3994_CR103","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.1038\/s41598-018-24879-x","volume":"8","author":"X Peng","year":"2018","unstructured":"Peng X, Zhang R, Duan G, Wang C, Sun N, Zhang L, Chen S, Fan Q, Xi Y (2018) Production and delivery of Helicobacter pylori NapA in Lactococcus lactis and its protective efficacy and immune modulatory activity. Sci Rep 8(1):6435","journal-title":"Sci Rep"},{"issue":"3","key":"3994_CR104","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1574-695X.2009.00605.x","volume":"57","author":"S-J Kim","year":"2009","unstructured":"Kim S-J, Lee JY, Jun DY, Song J-Y, Lee W-K, Cho M-J et al (2009) Oral administration of Lactococcus lactis expressing Helicobacter pylori Cag7-ct383 protein induces systemic anti-Cag7 immune response in mice. FEMS Immunol Med Microbiol 57(3):257\u201368. https:\/\/doi.org\/10.1111\/j.1574-695X.2009.00605.x","journal-title":"FEMS Immunol Med Microbiol"},{"key":"3994_CR105","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s10529-016-2173-5","volume":"38","author":"R Zhang","year":"2016","unstructured":"Zhang R, Duan G, Shi Q, Chen S, Fan Q, Sun N et al (2016) Construction of a recombinant Lactococcus lactis strain expressing a fusion protein of Omp22 and HpaA from Helicobacter pylori for oral vaccine development. Biotechnol Lett 38:1911\u20136. https:\/\/doi.org\/10.1007\/s10529-016-2173-5","journal-title":"Biotechnol Lett"},{"key":"3994_CR106","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00284-011-9920-6","volume":"62","author":"S Chen","year":"2011","unstructured":"Chen S, Zhang R, Duan G, Shi J (2011) Food-grade expression of Helicobacter pylori ureB subunit in Lactococcus lactis and its immunoreactivity. Curr Microbiol 62:1726\u20131731","journal-title":"Curr Microbiol"},{"key":"3994_CR107","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00253-005-0285-2","volume":"72","author":"S-J Kim","year":"2006","unstructured":"Kim S-J, Jun DY, Yang CH, Kim YH (2006) Expression of Helicobacter pylori cag12 gene in Lactococcus lactis MG1363 and its oral administration to induce systemic anti-Cag12 immune response in mice. Appl Microbiol Biotechnol 72:462\u201370. https:\/\/doi.org\/10.1007\/s00253-005-0285-2","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"3994_CR108","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/2049-632X.12173","volume":"72","author":"X Li","year":"2014","unstructured":"Li X, Xing Y, Guo L, Lv X, Song H, Xi T (2014) Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice. Pathogens Dis 72(1):78\u201386","journal-title":"Pathogens Dis"},{"key":"3994_CR109","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s10529-019-02740-z","volume":"41","author":"N Sun","year":"2019","unstructured":"Sun N, Zhang R, Duan G, Peng X, Wang C, Chen S et al (2019) A food-grade engineered Lactococcus lactis strain delivering Helicobacter pylori Lpp20 alleviates bacterial infection in H. pylori-challenged mice. Biotechnol Lett 41:1415\u201321. https:\/\/doi.org\/10.1007\/s10529-019-02740-z","journal-title":"Biotechnol Lett"},{"key":"3994_CR110","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10529-017-2502-3","volume":"40","author":"R Zhang","year":"2018","unstructured":"Zhang R, Wang C, Cheng W, Duan G, Shi Q, Chen S et al (2018) Delivery of Helicobacter pylori HpaA to gastrointestinal mucosal immune sites using Lactococcus lactis and its immune efficacy in mice. Biotechnol Lett 40:585\u2013590","journal-title":"Biotechnol Lett"},{"key":"3994_CR111","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s00284-008-9349-8","volume":"58","author":"XJ Zhang","year":"2009","unstructured":"Zhang XJ, Duan G, Zhang R, Fan Q (2009) Optimized expression of Helicobacter pylori ureB gene in the Lactococcus lactis nisin-controlled gene expression (NICE) system and experimental study of its immunoreactivity. Curr Microbiol 58:308\u201314. https:\/\/doi.org\/10.1007\/s00284-008-9349-8","journal-title":"Curr Microbiol"},{"issue":"1","key":"3994_CR112","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mcp.2013.08.003","volume":"28","author":"HX Zhang","year":"2014","unstructured":"Zhang HX, Qiu YY, Zhao YH, Liu XT, Liu M, Yu AL et al (2014) Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant. Mol Cellular Probes 28(1):25\u201330. https:\/\/doi.org\/10.1016\/j.mcp.2013.08.003","journal-title":"Mol Cellular Probes"},{"key":"3994_CR113","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s10529-009-9965-9","volume":"31","author":"D Song","year":"2009","unstructured":"Song D, Gu Q (2009) Surface expression of Helicobacter pylori urease subunit B gene E fragment on Lactococcus lactis by means of the cell wall anchor of Staphylococcus aureus protein A. Biotechnol Lett 31:985\u2013989","journal-title":"Biotechnol Lett"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-024-03994-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-024-03994-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-024-03994-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T21:03:47Z","timestamp":1736543027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-024-03994-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3994"],"URL":"https:\/\/doi.org\/10.1007\/s00284-024-03994-1","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"30"}}